By neochord-admin|2025-12-10T19:36:42-06:00November 10, 2016|Publications, Uncategorized|Comments Off on First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation;
By neochord-admin|2025-12-10T19:36:42-06:00November 2, 2016|Publications, Uncategorized|Comments Off on NeoChord passes 500 patient treatment milestone follow-up data on 127 patients out to two years presented at EACTS;
By neochord-admin|2025-12-10T19:36:42-06:00May 13, 2016|Publications, Uncategorized|Comments Off on NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation;
By neochord-admin|2025-12-10T19:36:42-06:00May 5, 2016|Publications, Uncategorized|Comments Off on NeoChord announces appointment of Alex Jonkers as VP of European Commercial Sales and milestone of over 400 patients treated with the DS1000 System;
By neochord-admin|2025-12-10T19:36:43-06:00March 1, 2016|Publications, Uncategorized|Comments Off on David H. Adams, MD and Michael A. Borger, MD PhD to Serve as National Principal Investigators for NeoChord’s U.S. Pivotal Trial.